Sugi Predict

Sugi Predict / Compounds / SCHEMBL574096

SCHEMBL574096

SCHEMBL574096

Clc1ccc2c(-c3ccccc3)c3ccccc3c(-c3ccccc3)c2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 1/20 0.53
▸ ESR2 Q92731 1/20 0.53
▸ DPP4 P27487 5/20 0.49
▸ MAP2 P11137 3/20 0.47
▸ CA1 P00915 4/20 0.46
▸ CA2 P00918 4/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ ROCK2 O75116 1/20 0.46
▸ MAP4K4 O95819 1/20 0.46
▸ LCK P06239 1/20 0.46
▸ CSF1R P07333 1/20 0.46
▸ PIM1 P11309 1/20 0.46
▸ RPS6KB1 P23443 1/20 0.46
▸ CDK2 P24941 1/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ EPHA2 P29317 1/20 0.46
▸ FLT3 P36888 1/20 0.46
▸ FRK P42685 1/20 0.46
▸ CLK2 P49760 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29416110 1.00 ESR1 (0.53) ESR1ESR2DPP4MAP2CA1
SCHEMBL25410041 0.94 DPP4 (0.48) ESR1ESR2DPP4MAP2CA1
SCHEMBL28190539 0.91 MAP2 (0.51) ESR1ESR2DPP4MAP2CA1
SCHEMBL15763552 0.91 ESR1 (0.46) ESR1ESR2DPP4MAP2CA1
SCHEMBL14076792 0.89 DPP4 (0.48) ESR1ESR2DPP4MAP2CA1
SCHEMBL14076789 0.88 CYP1A2 (0.50) ESR1ESR2DPP4MAP2CA1
SCHEMBL29770955 0.88 ESR1 (0.44) ESR1ESR2DPP4MAP2CA1
SCHEMBL23813397 0.88 ESR1 (0.44) ESR1ESR2DPP4MAP2CA1
SCHEMBL25625066 0.87 ESR1 (0.46) ESR1ESR2DPP4MAP2CA1
SCHEMBL27942362 0.87 ESR1 (0.62) ESR1ESR2DPP4MAP2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 241 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250084452-A1 BIOLOGICAL INDICATOR FOR DETERMINING THE EFFICACY OF A STERILIZATION PROCESS AND METHODS OF USE TERRAGENE LLC 2025-03-13 — — US claimed
US-11371085-B2 Reagents and methods for isothermal chain reaction MANCEBO RICARDO (US) 2022-06-28 — — US claimed
US-20210041362-A1 METHOD FOR CALIBRATING FLUORESCENT PLATE READERS PLEXBIO CO LTD (TW) 2021-02-11 — — US claimed
US-20200239945-A1 REAGENTS AND METHODS FOR ISOTHERMAL CHAIN REACTION MANCEBO RICARDO (US) 2020-07-30 — — US claimed
US-10612077-B2 Reagents and methods for isothermal chain reaction Mancebo, Ricardo (US) 2020-04-07 — — US claimed
US-20170284942-A1 METHOD FOR CALIBRATING FLUORESCENT PLATE READERS PLEXBIO CO., LTD (TW) 2017-10-05 — — US claimed
US-20120142014-A1 MOLECULAR INDICIA OF CELLULAR CONSTITUENTS AND RESOLVING THE SAME BY SUPER-RESOLUTION TECHNOLOGIES IN SINGLE CELLS CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2012-06-07 — — US claimed
WO-2011112634-A9 MOLECULAR INDICIA OF CELLULAR CONSTITUENTS AND RESOLVING THE SAME BY SUPER-RESOLUTION TECHNOLOGIES IN SINGLE CELLS CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2012-04-05 — — WO claimed
WO-2011112634-A2 MOLECULAR INDICIA OF CELLULAR CONSTITUENTS AND RESOLVING THE SAME BY SUPER-RESOLUTION TECHNOLOGIES IN SINGLE CELLS CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2011-09-15 — — WO claimed
JP-8012600-A — — None — — JP disclosed
US-12630868-B2 Multiplex labeling of molecules by sequential hybridization barcoding CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2026-05-19 — — US disclosed
US-12601007-B2 Multiplex labeling of molecules by sequential hybridization barcoding CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2026-04-14 — — US disclosed
US-12589165-B2 Methods for treating bladder tumors with viral nanoparticle conjugates and immune checkpoint inhibitors THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2026-03-31 — — US disclosed
US-12583948-B2 Photohardenable compositions, methods, and a stabilizer QUADRATIC 3D, INC. (US) 2026-03-24 — — US disclosed
US-20040016938-A1 Solid state white light emitter and display using same CREE, INC. 2004-01-29 — — US disclosed
US-6600175-B1 Solid state white light emitter and display using same ADVANCED TECHNOLOGY MATERIALS, INC. 2003-07-29 — — US disclosed
EP-0681019-B1 Phenylanthracene derivative and organic EL element TDK CORP (JP) 1999-09-01 — — EP disclosed
US-5635308-A STABLE, DURABLE ORGANIC ELECTROLUMINESCENT ELEMENTS TDK CORPORATION (JP) 1997-06-03 — — US disclosed
JP-H0812600-A PHENYLANTHRACENE DERIVATIVE AND ORGANIC EL ELEMENT TDK CORP 1996-01-16 — — JP disclosed
EP-0681019-A2 Phenylanthracene derivative and organic EL element TDK Corporation (JP) 1995-11-08 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12630868-B2 Multiplex labeling of molecules by sequential hybridization barcoding PHAX, SYNCRIP, NOP2 ESR1 1226/4885ESR2 2821/4885DPP4 3645/4885
US-12583948-B2 Photohardenable compositions, methods, and a stabilizer NOX4, LCP1, TERB1 ESR1 778/4885ESR2 1674/4885DPP4 4446/4885
US-12601007-B2 Multiplex labeling of molecules by sequential hybridization barcoding NOP2, POLI, FBL ESR1 903/4885ESR2 2745/4885DPP4 2461/4885
US-12589165-B2 Methods for treating bladder tumors with viral nanoparticle conjugates and immune checkpoint inhibitors CD274, PDCD1, PDCD1LG2 ESR1 2046/4885ESR2 4389/4885DPP4 1277/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.